Stockreport

CNS Pharmaceuticals Licenses Breakthrough Technology from MD Anderson, Doubling its Drug Pipeline

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF HOUSTON, Jan. 13, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of n [Read more]